Search Results - "Thuermann, P A"

Refine Results
  1. 1
  2. 2

    Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients by Schmiedl, S, Rottenkolber, M, Szymanski, J, Drewelow, B, Siegmund, W, Hippius, M, Farker, K, Guenther, I R, Hasford, J, Thuermann, P A

    Published in Expert opinion on drug safety (01-02-2018)
    “…Studies evaluating the impact of age and potentially inappropriate medication (PIM) on avoidable adverse drug reactions (ADRs) are scarce. In this prospective,…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5

    Detection of adverse drug reactions in a neurological department: Comparison between intensified surveillance and a computer-assisted approach by THUERMANN, Petra A, WINDECKER, Roland, STEFFEN, Joachim, SCHAEFER, Markus, TENTER, Ute, REESE, Erich, MENGER, Hermann, SCHMITT, Klaus

    Published in Drug safety (01-01-2002)
    “…Adverse drug reactions (ADRs) leading to hospitalisation or occurring during hospital stay contribute significantly to patient morbidity and mortality as well…”
    Get full text
    Journal Article
  6. 6

    Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics by Bakkum, Michiel J., Tichelaar, Jelle, Papaioannidou, Paraskevi, Likic, Robert, Sanz Alvarez, Emilio J., Christiaens, Thierry, Costa, João N., Mačiulaitis, Romaldas, Dima, Lorena, Coleman, Jamie, Richir, Milan C., Agtmael, Michiel A., Atanasova, Ivanka, Ganeva, Maria, Gatchev, Emil, Kostadinova, I. I., Mimica Matanovic, S., Vitezic, D, Greta, Wozniak, Kmonickova, E., Karel, Urbanek, Damkier, P., Huupponen, R. K., Auffret, Marine, Bejan‐Angoulvant, T., Laurent, Chouchana, Jean‐Luc, Cracowski, Drici, M. D., Faillie, J. L., Hélène, Geniaux, Molimard, M., Orlikowski, D., Palin, Karine, Pers, Y.‐M., Picard, Nicolas, Simon, N., Toussirot, E., Boger, R. H., Cascorbi, I., Mueller, S. C., Regenthal, R., Schwab, M., Schwaninger, M. S., Thuermann, P. A., Wojnowski, L., Kouvelas, D., Riba, P., Kerins, David M., Williams, David J., Cosentino, M., De Ponti, Fabrizio, Filippelli, Amelia, Leone, R., Locatelli, Vittorio, Jansone, Baiba, Gulbinovic, Romaldas, Mifsud, Janet, Braszko Jan, J., Kocic, I., Luiza, Breitenfeld, Castelo‐Branco, M., Simona, Conea, Ioan, Magyar, Bevc, S., Mojca, Krzan, Bernal, M. L., Capellà, D., Carcas, A., De Abajo, F. J., Lopez‐Rico, M., Lucena, M. I., Pontes, C., Sanz, E. J., Böttiger, Y., Le Grevès, Madeleine, Waard‐Siebinga, I., Janssen Ben, J. A., Wilma, Knol, Rahul, Pandit, Rosse, F., Dent, G., Albert, Ferro, Hitchings, A. W., Kapil, V., Linton, K. D., Loke, Y. K., Michael, Okorie, David, Plumb Richard, Pontefract, Sarah, Ranmuthu, S., Sampson, A. P., Thanacoody, H. K. R., Whitfield Jonathan, P., Wilson, Kurt

    Published in British journal of clinical pharmacology (01-03-2021)
    “…Aim Improvement and harmonization of European clinical pharmacology and therapeutics (CPT) education is urgently required. Because digital educational…”
    Get full text
    Journal Article
  7. 7

    Adverse Drug Reactions in a Complementary Medicine Hospital: A Prospective, Intensified Surveillance Study by Ostermann, Thomas, Tabali , M., Jeschke, E., Lüke, C., Thürmann, P. A., Süsskind, M., Matthes, H.

    “…Anthroposophic medicine is one of the widely used approaches of complementary and alternative medicine. However, few prospective studies have generated safety…”
    Get full text
    Journal Article
  8. 8

    Drug treatment of elderly patients by Thürmann, P A, Schmiedl, S

    “…Drug therapy in seniors needs to be adapted to the capacity of the aged organism. The dosages of a high number of drugs from several classes (e.g.,…”
    Get full text
    Journal Article
  9. 9

    Detecting adverse drug reactions on paediatric wards : Intensified surveillance versus computerised screening of laboratory values by HAFFNER, Steffen, VON LANE, Nicoletta, WIRTH, Stefan, THÜRMAM, Petra A

    Published in Drug safety (01-01-2005)
    “…Adverse drug reactions (ADRs) contribute significantly to patient morbidity and mortality, as well as to costs for healthcare systems. Our aim was to evaluate…”
    Get full text
    Journal Article
  10. 10

    Chemotherapy in patients with colorectal carcinoma: applicability of data from clinical trials for the individual patient by Thürmann, P A

    Published in Zentralblatt für Chirurgie (01-02-2008)
    “…Randomised, controlled clinical trials provide a valid foundation for evidence-based clinical guidelines. The representativeness of the patient population…”
    Get more information
    Journal Article
  11. 11

    Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations by Rottenkolber, Dominik, Schmiedl, Sven, Rottenkolber, Marietta, Farker, Katrin, Saljé, Karen, Mueller, Silke, Hippius, Marion, Thuermann, Petra A., Hasford, Joerg

    Published in Pharmacoepidemiology and drug safety (01-06-2011)
    “…ABSTRACT Purpose German hospital reimbursement modalities changed as a result of the introduction of Diagnosis Related Groups (DRG) in 2004. Therefore, no data…”
    Get full text
    Journal Article
  12. 12

    Methods and systems to detect adverse drug reactions in hospitals by Thuermann, P A

    Published in Drug safety (2001)
    “…Detection of adverse drug reactions (ADRs) in hospitals offers the chance to detect serious ADRs resulting in hospitalisation and ADRs occurring in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Influence of drugs on urological diseases by Thürmann, P A

    Published in Urologe. Ausgabe A (01-03-2016)
    “…A number of drugs prescribed for the treatment of various diseases can induce urological symptoms as side effects. Antihypertensive drugs (particularly alpha…”
    Get full text
    Journal Article
  16. 16

    Detection of drug-related adverse events in hospitals by Thürmann, Petra A

    Published in Expert opinion on drug safety (01-09-2003)
    “…Adverse drug events (ADEs) contribute significantly to patient morbidity and mortality as well as to cost for healthcare providers and society. Since only…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Drug-Induced Blood Consumption: The Impact of Adverse Drug Reactions on Demand for Blood Components in German Departments of Internal Medicine by Rottenkolber, Dominik, Schmiedl, Sven, Rottenkolber, Marietta, Thuermann, Petra A., Hasford, Joerg

    Published in Basic & clinical pharmacology & toxicology (01-10-2012)
    “…Therapy for adverse drug reactions (ADRs) often results in the application of blood components. This study aims to assess the demand for blood components and…”
    Get full text
    Journal Article
  19. 19

    Gender-related differences in pharmacokinetics and pharmacodynamics by Thürmann, P A

    “…Following the negative experience with thalidomide, women were excluded from participation in clinical trials with new pharmaceutical agents as far as…”
    Get full text
    Journal Article
  20. 20